Home » Authors » Brady Huggett

Articles by Brady Huggett

Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner

Feb. 25, 2003

By Brady Huggett

Peregrine Gets FDA OK For Cotara Phase III, Awaits Partner

Feb. 25, 2003

By Brady Huggett

BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme

Feb. 24, 2003

By Brady Huggett

BioMarin Raises $75M Publicly, Gets Good News On Aldurazyme

Feb. 24, 2003

By Brady Huggett

Biogen's Amevive Shot Down In Europe; Approval Years Away

Feb. 21, 2003

By Brady Huggett

SomaLogic Raises $19.5M To Develop Proteomics Products

Feb. 21, 2003

By Brady Huggett

Biogen's Amevive Shot Down In Europe; Approval Years Away

Feb. 21, 2003

By Brady Huggett

SomaLogic Raises $19.5M To Develop Proteomics Products

Feb. 21, 2003

By Brady Huggett

BattellePharma Raises $22M To Develop Inhalation Program

Feb. 20, 2003

By Brady Huggett

BattellePharma Raises $22M To Develop Inhalation Program

Feb. 20, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...